1997
DOI: 10.1001/archopht.1997.01100160456013
|View full text |Cite
|
Sign up to set email alerts
|

Subconjunctival Carboplatin Therapy and Cryotherapy in the Treatment of Transgenic Murine Retinoblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
1
2

Year Published

1998
1998
2006
2006

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(30 citation statements)
references
References 32 publications
0
27
1
2
Order By: Relevance
“…Local delivery of chemotherapeutic agents (carboplatin) by periocular (subtenon) or intraocular injections has been experimented in animals (Murray et al, 1997;Van Quill et al, 2005) and used in selected retinoblastoma patients with some success. It is not, however, without risk and at the present time does in no way Diagnosis and current management of retinoblastoma A Balmer et al present an alternative to systemic chemotherapy.…”
Section: Future Managementmentioning
confidence: 99%
“…Local delivery of chemotherapeutic agents (carboplatin) by periocular (subtenon) or intraocular injections has been experimented in animals (Murray et al, 1997;Van Quill et al, 2005) and used in selected retinoblastoma patients with some success. It is not, however, without risk and at the present time does in no way Diagnosis and current management of retinoblastoma A Balmer et al present an alternative to systemic chemotherapy.…”
Section: Future Managementmentioning
confidence: 99%
“…Animal models have shown that carboplatin penetrates the sclera into the vitreous cavity, allowing for effective higher dosages at that site. [46][47][48][49] Initially, subconjunctival carboplatin alone …”
Section: Subconjunctival Chemoreduction For Retinoblastomamentioning
confidence: 99%
“…Similar to the clinical trials, there have been many reports studying the use of focal therapy treatment, such as EBRT and cryotherapy, alone or in combination with chemotherapy treatments or chemotherapy alone in the large T antigen mouse model [64,118]. From these studies it appeared that the combination of focal therapy and the combination of carboplatin with EBRT had the most success.…”
Section: Summary Of Preclinical Trialsmentioning
confidence: 99%
“…A direct intravitreal injection was not feasible because of the risk of damaging the eye and the possibility disseminating tumor cells. Nevertheless, researchers circumvented this obstacle with by injecting in the surrounding orbital area [61][62][63][64]. Based on these studies, Abramson!s group conducted a clinical study which treated patients with only subconjunctival injections of carboplatin [65].…”
Section: History Of Clinical Treatmentmentioning
confidence: 99%
See 1 more Smart Citation